Drug Master Files for: etravirine
✉ Email this page to a colleague
etravirine Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
20440 | A | II | 4/18/2007 | JANSSEN PHARMACEUTICA NV | ETRAVIRINE (R165335) DRUG SUBSTANCE |
25550 | A | II | 12/1/2011 | HETERO LABS LTD | ETRAVIRINE |
27923 | I | II | 3/7/2014 | APOTEX PHARMACHEM INDIA PVT LTD | ETRAVIRINE |
28813 | A | II | 12/22/2014 | MYLAN LABORATORIES LTD | ETRAVIRINE |
29404 | A | II | 5/31/2015 | MSN LIFE SCIENCES PRIVATE LTD | ETRAVIRINE [ROUTE CODE EV] |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information